Molecular typing of Neisseria gonorrhaeae causing repeated infections: Evolution of porin during passage within a community

Journal of Infectious Diseases

Volumn 179, Issue 2, 1999, Pages 371-381

  Hobbs, Marcia M ^a   Alcorn, Timothy M ^b   Davis, Rachael H ^c   Fischer, William ^c   Thomas, James C ^c   Martin, Iona ^c   Ison, Catherine ^c   Sparling, P F ^c   Cohen, Myron S ^c  

^a LABORATORY CORPORATION OF AMERICA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

PORIN;

AMINO ACID SEQUENCE; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; GENE SEQUENCE; GENETIC VARIABILITY; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT INFECTION; SEQUENCE ANALYSIS; SEROTYPING;

AMINO ACID SEQUENCE; COMMUNITY HEALTH SERVICES; GONORRHEA; HUMANS; MOLECULAR SEQUENCE DATA; NEISSERIA GONORRHOEAE; NORTH CAROLINA; PHYLOGENY; POLYMERASE CHAIN REACTION; PORINS; SEQUENCE HOMOLOGY, AMINO ACID; SEROTYPING;

EID: 0032979737     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314608     Document Type: Article

References (59)

1. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992;19:61-77.
2. Swanson J, Belland RJ, Hill SA. Neisserial surface variation: how and why? Curr Opin Genet Dev 1992;2:805-11.
3. Boslego JW, Tramont EC, Chung RC, et al. Efficacy trial of a parenteral gonococcal pilus vaccine in men. Vaccine 1991;9:154-62.
4. Zak K, Diaz JL, Jackson D, Heckels JE. Antigenic variation during infection with Neisseria gonorrhoeae: detection of antibodies to surface proteins in sera of patients with gonorrhea. J Infect Dis 1984;149:166-74.
5. Brunham RC, Plummer FA, Stephens RS. Bacterial antigenic variation, host immune response, and pathogen-host coevolution. Infect Immun 1993;61:2273-6.
6. Adimora AA, Sparling PF, Cohen MS. Vaccines for classic sexually transmitted diseases. Infect Dis Clin North Am 1994;8:859-76.
7. Meitzner TA, Cohen MS. Vaccines against gonococcal infection. In: Levine MM, Woodrow GC, Kaper JB, Cobon GS, eds. New generation vaccines. 2nd ed. New York: Marcel Dékker, 1997;817-42.
8. Douglas JT, Lee MD, Nikaido H. Protein I of Neisseria gonorrhoeae outer membrane is a porin. FEMS Microbiol Lett 1988;12:305-9.
9. Knapp JS, Tam MR, Nowinski RC, Holmes KK, Sandstrom EG. Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J Infect Dis 1984;50:44-8.
10. Lammel CJ, Sweet RL, Rice PA, et al. Antibody-antigen specificity in the immune response to infection with Neisseria gonorrhoeae. J Infect Dis 1985;152:990-1000.
11. O'Reilly RJ, Lee L, Welch BG. Secretory IgA antibody responses to Neisseria gonorrhoeae in the genital secretions of infected females. J Infect Dis 1976;133:113-25.
12. McMillan A, McNeillage G, Young H, Bain SS. Secretory antibody response of the cervix to infection with Neisseria gonorrhoeae. Br J Vener Dis 1979;55:265-70.
13. Plummer FA, Simonsen JN, Chubb H, et al. Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J Clin Invest 1989;83:1472-6.
14. Young H, Moyes A, Ross J, McMillan A. A serovar analysis of heterosexual gonorrhoea in Edinburgh, 1986-90. Genitourin Med 1992;68:16-9.
15. Fox KK, Thomas JC, Weiner DH, Davis RH, Sparling PF, Cohen MS. Longitudinal evaluation of serovar-specific immunity to Neisseria gonorrhoeae. Am J Epidemiol 1999 149:(in press).
16. Thomas JC, Pierce RL, Sparling PF, et al. Demographic and behavioral characteristics of gonococcal serovar infection networks [abstract O113]. In: Program and abstracts: International Congress of Sexually Transmitted Diseases, Seville, Spain, 1997;80.
17. Cooke SJ, de la Paz H, La Poh C, Ison CA, Heckels JE. Variation within serovars of Neisseria gonorrhoeae detected by structural analysis of outer-membrane protein PIB and by pulsed-field gel electrophoresis. Microbiology 1997;143:1415-22.
18. Mee BJ, Thomas H, Cooke SJ, Lambden PR, Heckels JE. Structural comparison and epitope analysis of outer-membrane PIA from strains of Neisseria gonorrhoeae with differing serovar specificities. J Gen Microbiol 1993;139:2613-20.
19. Butt NJ, Lambden PR, Heckels JE. Gonococcal outer-membrane protein PIB: comparative sequence analysis and localization of epitopes which are recognized by type-specific and cross-reacting monoclonal antibodies. J Gen Microbiol 1990;136:2165-72.
20. Poh CL, Lau QC. Subtyping of Neisseria gonorrhoeae auxotype-serovar groups by pulsed-field gel electrophoresis. J Med Microbiol 1993;38:366-70.
21. Woods CR, Koeuth T, Estabrook MM, Lupski JR. Rapid determination of outbreak-related strains of Neisseria meningitidis by repetitive element-based polymerase chain reaction genotyping. J Infect Dis 1996;174:760-7.
22. O'Rourke M, Ison CA, Renton AM, Spratt BG. Opa-typing: a high resolution tool for studying the epidemiology of gonorrhoea. Mol Microbiol 1995;17:865-75.
23. Abdillahi H, Poolman JT. Whole-cell ELISA typing of Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol Lett 1987;48:367-71.
24. Akopyanz N, Bukanov NO, Westblom TU, Kresovich S, Berg DE. DNA diversity among clinical isolates of Helicobacter pylori detected by PCR-based RAPD fingerprinting. Nucleic Acids Res 1992;20:5137-42.
25. Kersulyte D, Woods JP, Keath EJ, Goldman WE, Berg DE. Diversity among clinical isolates of Histoplasma capsulatum detected by polymerase chain reaction with arbitrary primers. J Bacteriol 1992;174:7075-9.
26. Woods JP, Kersulyte D, Tolan RW Jr, Berg CM, Berg DE. Use of arbitrarily primed polymerase chain reaction analysis to type disease and carrier strains of Neisseria meningitidis isolated during a university outbreak. J Infect Dis 1994;169:1384-9.
27. Carbonetti NH, Simnad VI, Seifert HS, So M, Sparling PF. Genetics of protein I of Neisseria gonorrhoeae: construction of hybrid porins. Proc Natl Acad Sci USA 1988;85:6841-5.
28. van der Ley P, Heckels JE, Virji M, Hoogerhout P, Poolman JT. Topology of outer membrane porins in pathogenic Neisseria species. Infect Immun 1991;59:2963-71.
29. Plummer FA, Brunham RC. Gonococcal recidivism, diversity, and ecology. Rev Infect Dis 1987;9:846-50.
30. Zhu T, Mo H, Wang N, et al. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993;261:1179-81.
31. Woods JP, Kersulyte D, Goldman WE, Berg DE. Fast DNA isolation from Histoplasma capsulatum: methodology for arbitrary primer polymerase chain reaction-based epidemiological and clinical studies. J Clin Microbiol 1993;31:463-4.
32. Vasquez JA, Berron S, O'Rourke M, et al. Interspecies recombination in nature: a meningococcus that has acquired a gonococcal PIB porin. Mol Microbiol 1995;15:1001-7.
33. Thomas JC, Tucker M. The development and use of the concept of a sexually transmitted disease core. J Infect Dis 1995;174:S134-43.
34. Elkins C, Carbonetti NH, Coimbre AJ, Thomas CE, Sparling PF. Cloning and constitutive expression of structural genes encoding gonococcal porin protein in Escherichia coli and attenuated Salmonella typhimurium vaccine strains. Gene 1994;138:43-50.
35. Wetzler LM, Blake MS, Barry K, Gotschlich EC. Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants. J Infect Dis 1992;166:551-5.
36. Wetzler LW, Ho Y, Reiser H. Neisserial porins induce B lymphocytes to express costimulatory B7-2 molecules and to proliferate. J Exp Med 1996;183:1151-9.
37. Wetzler LM, Blake MS, Gotschlich EC. Characterization and specificity of antibodies to protein I of Neisseria gonorrhoeae produced by injection with various protein I-adjuvant preparations. J Exp Med 1988;168:1883-97.
38. Hook EW, Handsfield HH. Gonococcal infections in the adult. In: Holmes KK, Mardh PA, Sparling PF, et al, eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill Information Services, 1990;149-65.
39. Buchanan TM, Swanson J, Holmes KK, Kraus SJ, Gotschlich EC. Quantitative determination of antibody to gonococcal pili; changes in antibody levels with gonococcal infection. J Clin Invest 1973;52:2896-909.
40. Rice PA. Molecular basis for serum resistance in Neisseria gonorrhoeae. Clin Microbiol Rev 1989(suppl 2);S112-7.
41. Plummer FA, Chubb H, Simonsen JN, et al. Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection. J Clin Invest 1993;91:339-43.
42. Brooks GF, Darrow WW, Day JA. Repeated gonorrhea: an analysis of importance and risk factors. J Infect Dis 1978;137:161-9.
43. Barnes RC, Holmes KK. Epidemiology of gonorrhea: current perspectives. Epidemiol Rev 1984;6:1-30.
44. Oh MK, Cloud GA, Fleenor M, Sturdevant MS, Nesmith JD, Feinstein RA. Risk for gonococcal and chlamydial cervicitis in adolescent females: incidence and recurrence in a prospective cohort study. J Adolesc Health 1996;18:270-5.
45. Li H, Dillon J. Utility of ribotyping, restriction endonuclease analysis and pulse-field gel electrophoresis to discriminate between isolates of Neisseria gonorrhoeae of serovar IA-2 which require arginine, hypoxanthine or uracil for growth. J Med Microbiol 1995;43:208-15.
46. Poh CL, Loh GK, Tapsall JW. Resolution of clonal subgroups among Neisseria gonorrhoeae IB-2 and IB-6 serovars by pulsed-field gel electrophoresis. Genitourin Med 1995;71:145-9.
47. Poh CL, Lau QC, Chow VT. Differentiation of Neisseria gonorrhoeae IB-3 and IB-7 serovars by direct sequencing of protein IB gene and pulsed-field gel electrophoresis. J Med Microbiol 1995;43:201-7.
48. Camarena JJ, Nogueira JM, Dasi MA, et al. DNA amplification fingerprinting for subtyping Neisseria gonorrhoeae strains. Sex Transm Dis 1995;22:128-36.
49. Zhu X, Kong F, Zhang G, Chen S. Identification and classification of Neisseria gonorrhoeae by RAPD fingerprinting. Chin Med J (Engl) 1995;108:269-72.
50. Hobbs MM, Seiler A, Achtman M, Cannon JG. Microevolution within a clonal population of pathogenic bacteria: recombination, gene duplication and horizontal genetic exchange in the opa gene family of Neisseria meningitidis. Mol Microbiol 1994;12:171-80.
51. Halter R, Pohlner J, Meyer TF. Mosaic-like organization of IgA protease genes in Neisseria gonorrhoeae generated by horizontal genetic exchange in vivo. EMBO J 1989;8:2737-44.
52. Feavers IM, Heath AB, Bygraves JA, Maiden MCJ. Role of horizontal genetic exchange in the antigenic variation of the class I outer membrane protein of Neisseria meningitidis. Mol Microbiol 1992;6:481-95.
53. Spratt BG, Bowler LD, Zhang Q, Maynard Smith J. Role of interspecies transfer of chromosomal genes in the evolution of penicillin resistance in pathogenic and commensal Neisseria species. J Mol Evol 1992;34:115-25.
54. Lomholt H, Poulsen K, Caugant DA, Kilian M. Molecular polymorphism and epidemiology of Neisseria meningitidis immunoglobulin A1 proteases. Proc Natl Acad Sci USA 1992;89:2120-4.
55. Gill MJ, Jayamohan J, Lessing MP, Ison CA. Naturally occurring PIA/PIB hybrids of Neisseria gonorrhoeae. FEMS Microbiol Lett 1994;119:161-6.
56. Lau QC, Chow VT, Poh CL. Polymerase chain reaction and direct sequencing of Neisseria gonorrhoeae protein PIB gene: partial nucleotide and amino acid sequence analysis of strains S4, S11, S48 (serovar IB4) and S34 (serovar IB5). Med Microbiol Immunol 1993;182:137-45.
57. Poh CL, Ramachandran V, Tapsall JW. Genetic diversity of Neisseria gonorrhoeae IB-2 and IB-6 isolates revealed by whole-cell repetitive element sequence-based PCR. J Clin Microbiol 1996;34:292-5.
58. Smith NH, Maynard Smith J, Spratt BG. Sequence evolution of the porB gene of Neisseria gonorrhoeae and Neisseria meningitidis: evidence of positive Darwinian selection. Mol Biol Evol 1995;12:363-70.
59. Hedges SR, Sibley DA, Mayo MS, Hook EW, Russell MW. Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections. J Infect Dis 1998;178:742-51.